Evidence map›Paper›PMID 41291138›Full record

ArticleJournal of assisted reproduction and genetics2026

Reproductive outcomes of mosaic embryo transfers in preimplantation genetic testing for structural rearrangement cycles: a retrospective cohort study.

Jiandong Shen, Jiazi Xie, Xueping Sun, Wei Wu, Heng Xu, Mengdi Ge, Dongmei Hu, Lingbo Cai, Xiang Ma, Jiayin Liu and 2 more

Abstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiandong ShenState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.ORCID http://orcid.org/0000-0002-3199-6993
Jiazi XieState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Xueping SunState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Wei WuState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Heng XuState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Mengdi GeState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Dongmei HuMingguang People's Hospital, Mingguang , Anhui Province, 239400, China.
Lingbo CaiState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Xiang MaState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Jiayin LiuState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China.
Feiyang DiaoState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China. phenix_y@163.com.
Han ZhaoState Key Laboratory of Reproductive Medicine and Offspring Health, Clinical Center of Reproductive Medicine, the First Affiliated Hospital With Nanjing Medical University, Yongqing Lane 16, Nanjing, Jiangsu Province, 210029, China. hanzh80@sdu.edu.cn.

Funding

Key Technologies Research and Development Program 2021YFC2700600Key Technologies Research and Development Program 2022YFC2703200National Natural Science Foundation of China 82171839
6 · The paper itself

Abstract

purposeTo study reproductive outcomes of transferring embryos with mosaic chromosomal aneuploidies unrelated to target loci in preimplantation genetic testing for structural rearrangement (PGT-SR).

methodsA retrospective analysis of 1712 PGT-SR cycles (involving 1373 couples) from a single center was conducted. Comprehensive chromosomal analysis was performed on trophectoderm biopsy samples using whole-genome amplification combined with next-generation sequencing. Clinical outcomes after single embryo transfer, including clinical pregnancy rate, miscarriage rate, live birth rate, and ectopic pregnancy rate, were compared between mosaic embryo transfers and completely euploid embryo transfers.

resultsIn PGT-SR cycles, euploid embryo transfers (1338 cycles) demonstrated a clinical pregnancy rate of 65.17%, live birth rate of 58.67%, miscarriage rate of 6.05%, and ectopic pregnancy rate of 0.45%, whereas mosaic embryo transfers (165 cycles) exhibited comparable outcomes with 58.18%, 54.55%, 3.64%, and 0%, respectively. The subgroup analysis by mosaic degree which revealed low-level mosaicism (20%-29% and 30%-49%) had outcomes similar to euploid embryos. High-level mosaicism (50%-69%) demonstrated significantly reduced clinical pregnancy (OR = 0.20, 95% CI 0.06-0.54) and live birth rates (OR = 0.20, 95% CI 0.06-0.56), though miscarriage remained comparable. No significant outcome variations were observed across chromosomal types.

conclusionsIn PGT-SR cycles, embryos with low-level mosaicism (20%-49%) unrelated to target loci demonstrate equivalent clinical pregnancy and live birth outcomes to completely euploid embryos. Although high-level mosaicism (50%-69%) is likely associated with reduced live birth rates, these embryos still retain potential for healthy live births.

Indexed as

Embryo TransferMosaicismPreimplantation DiagnosisAbortion, SpontaneousAdultAneuploidyFemaleFertilization in VitroGenetic TestingHumansLive BirthPregnancyPregnancy OutcomePregnancy RateRetrospective StudiesIn vitro fertilizationMosaic embryoPreimplantation genetic testingReproductive outcomesStructural rearrangements

Identifiers

PMID41291138
PMCPMC12831792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.